Walgreens Boots Alliance Inc (WBA) Stock
WBA is no longer traded. Walgreens Boots Alliance was taken private by Sycamore Partners on August 28, 2025.
Each WBA share was exchanged for $11.45 in cash plus a contingent value right of up to $3.00. Prices on this page are historical; the last trade was August 27, 2025 at $11.98.
Walgreens Boots Alliance stock price history
WBA final trading statistics
- Final close
- $11.98
- Final trading day
- Aug 27, 2025
- Market cap at delisting
- $10.37B
- Shares outstanding
- 865.56M
- Final 52-week range
- $8.08 – $13.25
- Avg. volume (final 3 mo.)
- 16,941,765
- All-time high (split-adj.)
- $66.35 · Aug 2015
- All-time low (split-adj.)
- $0.47 · Nov 1984
- Return since IPO
- +2280.8%
- Beta
- 0.77
- Book value / share
- $8.30
- Price / book
- 1.44
Walgreens Boots Alliance annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2024 | $147.66B | -$8.6B | $2.88 |
| FY2023 | $139.08B | -$3.1B | $3.99 |
| FY2022 | $132.70B | $4.3B | $5.03 |
| FY2021 | $132.51B | $2.5B | $5.03 |
| FY2020 | $121.98B | $456.0M | $4.74 |
Last five fiscal years reported before the delisting; fiscal year ending August. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Walgreens Boots Alliance Inc
Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, Germany, the United Kingdom, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise. The International segment offers sale of prescription drugs and health and wellness, beauty, personal care, and other consumer products outside the United States; and operates pharmacy-led health and beauty retail businesses under the Boots brand stores in the United Kingdom, the Republic of Ireland, and Thailand, as well as the Benavides brand in Mexico and the Ahumada brand in Chile. The U.S. Healthcare segment provides VillageMD, a national provider of value-based care with primary, multi-specialty, and urgent care providers serving patients in traditional clinic settings, in patients' homes and online appointments; Shields, a specialty pharmacy integrator and accelerator for hospitals; and CareCentrix, a participant in the post-acute and home care management sectors. Walgreens Boots Alliance, Inc. was founded in 1909 and is headquartered in Deerfield, Illinois.
Walgreens Boots Alliance stock FAQ
What happened to Walgreens Boots Alliance stock?
Walgreens Boots Alliance was taken private by Sycamore Partners on August 28, 2025. Shareholders received $11.45 in cash plus a contingent value right of up to $3.00 for each share. WBA stock stopped trading on the Nasdaq, with a final close of $11.98 on August 27, 2025.
What did Walgreens Boots Alliance shareholders receive?
Each WBA share was converted into $11.45 in cash plus a contingent value right of up to $3.00. The deal was valued at about $10 billion.
Is WBA stock still trading?
No. WBA was delisted from the Nasdaq on August 28, 2025 and no longer trades on a U.S. exchange.
What was the last price of WBA stock?
WBA closed at $11.98 on its final trading day, August 27, 2025, for a market value of about $10.37B.
What were Walgreens Boots Alliance's revenue and earnings in its last full fiscal year?
Walgreens Boots Alliance reported revenue of $147.66B and net income of -$8.6B in fiscal 2024, its last full year as a public company.
When did Walgreens Boots Alliance go public?
Walgreens Boots Alliance Inc stock began trading on July 1, 1985.